ACETAMINOPHEN 325MG and COUGH

Overview

COUGH is the #12 most commonly reported adverse reaction for ACETAMINOPHEN 325MG, manufactured by Allegiant Health. There are 7 FDA adverse event reports linking ACETAMINOPHEN 325MG to COUGH. This represents approximately 1.8% of all 383 adverse event reports for this drug.

Patients taking ACETAMINOPHEN 325MG who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for ACETAMINOPHEN 325MG, but still significant enough to appear in the safety profile.

Other Side Effects of ACETAMINOPHEN 325MG

In addition to cough, the following adverse reactions have been reported for ACETAMINOPHEN 325MG:

• INFUSION RELATED REACTION — 31 reports
• NAUSEA — 19 reports
• HEADACHE — 15 reports
• DEATH — 13 reports
• DYSPNOEA — 13 reports
• VOMITING — 13 reports
• RASH — 12 reports
• DIARRHOEA — 9 reports
• FATIGUE — 9 reports
• CHEST DISCOMFORT — 7 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does ACETAMINOPHEN 325MG cause COUGH?

COUGH has been reported as an adverse event in 7 FDA reports for ACETAMINOPHEN 325MG. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with ACETAMINOPHEN 325MG?

COUGH accounts for approximately 1.8% of all adverse event reports for ACETAMINOPHEN 325MG, making it a notable side effect.

What should I do if I experience COUGH while taking ACETAMINOPHEN 325MG?

If you experience cough while taking ACETAMINOPHEN 325MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages